Informations générales (source: ClinicalTrials.gov)

NCT03020251 En recrutement
Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer (Rexochir)
Interventional
  • Tumeurs du poumon
N/A
Centre Jean Perrin (Voir sur ClinicalTrials)
mai 2017
septembre 2025
20 septembre 2024
This randomized controlled trial will evaluate the effect of a preoperative rehabilitation program at home in patients resected for lung cancer, comparing a control group (C group) receiving only chest physiotherapy and a rehabilitation group (R group) receiving both a training program at home and chest physiotherapy

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre Jean Perrin - 63011 - Clermont-Ferrand - France Marc Filaire, Pr En recrutement Contact (sur clinicalTrials)
CHU Clermont Ferrand, Gabriel Montpied, service de médecine du sport et explorations fonctionnelles, - 63000 - Clermont-Ferrand - France Frédéric Coste, MD Recrutement non commencé Contact (sur clinicalTrials)
CHU Grenoble, Hôpital Michallon - 38700 - Grenoble - France Yves Brichon, Pr Recrutement non commencé Contact (sur clinicalTrials)
Hospices Civiles de Lyon, groupement hospitalier Est, Hopital Louis Pradel - 69677 - Lyon - France François Tronc, Pr Recrutement non commencé Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre de Recherche en Nutrition Humaine - 63009 - Clermont-Ferrand - France Ruddy Richard, Pr Recrutement non commencé Contact (sur clinicalTrials)
CHU Saint-Etienne, CHU Hopital Nord - 42055 - Saint Etienne - France Olivier Tiffet, Pr Recrutement non commencé Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible
for resection surgery (lobectomy or pneumonectomy)

- Age > 18 years

- Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced
expiratory volume (FEV )/ forced vital capacity (FVC) <70%, FEV <80% of predicted)
and Exertional dyspnea stage MMRC (Medical Research Council) > 1

- Patients must provide written consent

- Member of social security scheme



- Patients refusing to participate

- COPD stage 1 Gold (VEMS >= 80% of the theoretical value)

- Presenting an operating contraindication during the initial maximal exercise test

- Presenting cardiac or vascular contraindication to achieve the readaptation program

- Patient living alone at home

- Patient with ventilatory assistance at home (oxygen therapy or noninvasive
ventilation (NIV))

- With exercise hypoventilation (PaCO2 >45 mmHg)

- Cognitive difficulty

- unable major

- pregnancy,

- patients deprived of liberty by a court or administrative decision